A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Cirulli, Elizabeth TNicoletti, Paola
Abramson, Karen
Andrade, Raul J
Bjornsson, Einar S
Chalasani, Naga
Fontana, Robert J
Hallberg, Pär
Li, Yi Ju
Lucena, M Isabel
Long, Nanye
Molokhia, Mariam
Nelson, Matthew R
Odin, Joseph A
Pirmohamed, Munir
Rafnar, Thorunn
Serrano, Jose
Stefánsson, Kári
Stolz, Andrew
Daly, Ann K
Aithal, Guruprasad P
Watkins, Paul B
Issue Date
2019-05
Metadata
Show full item recordCitation
A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury. 2019, 156(6):1707-1716 GastroenterologyAbstract
We performed genetic analyses of a multiethnic cohort of patients with idiosyncratic drug-induced liver injury (DILI) to identify variants associated with susceptibility. We performed a genome-wide association study of 2048 individuals with DILI (cases) and 12,429 individuals without (controls). Our analysis included subjects of European (1806 cases and 10,397 controls), African American (133 cases and 1,314 controls), and Hispanic (109 cases and 718 controls) ancestry. We analyzed DNA from 113 Icelandic cases and 239,304 controls to validate our findings. We associated idiosyncratic DILI with rs2476601, a nonsynonymous polymorphism that encodes a substitution of tryptophan with arginine in the protein tyrosine phosphatase, nonreceptor type 22 gene (PTPN22) (odds ratio [OR] 1.44; 95% confidence interval [CI] 1.28-1.62; P = 1.2 × 10 In a genome-wide association study, we identified rs2476601 in PTPN22 as a non-HLA variant that associates with risk of liver injury caused by multiple drugs and validated our finding in a separate cohort. This variant has been associated with increased risk of autoimmune diseases, providing support for the concept that alterations in immune regulation contribute to idiosyncratic DILI.Description
To access publisher's full text version of this article click on the hyperlink belowAdditional Links
https://www.sciencedirect.com/science/article/pii/S0016508519300940https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511989/
ae974a485f413a2113503eed53cd6c53
10.1053/j.gastro.2019.01.034
Scopus Count
Collections
Related articles
- Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.
- Authors: Lucena MI, Molokhia M, Shen Y, Urban TJ, Aithal GP, Andrade RJ, Day CP, Ruiz-Cabello F, Donaldson PT, Stephens C, Pirmohamed M, Romero-Gomez M, Navarro JM, Fontana RJ, Miller M, Groome M, Bondon-Guitton E, Conforti A, Stricker BH, Carvajal A, Ibanez L, Yue QY, Eichelbaum M, Floratos A, Pe'er I, Daly MJ, Goldstein DB, Dillon JF, Nelson MR, Watkins PB, Daly AK, Spanish DILI Registry., EUDRAGENE., DILIN., DILIGEN., International SAEC.
- Issue date: 2011 Jul
- Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
- Authors: Nicoletti P, Aithal GP, Bjornsson ES, Andrade RJ, Sawle A, Arrese M, Barnhart HX, Bondon-Guitton E, Hayashi PH, Bessone F, Carvajal A, Cascorbi I, Cirulli ET, Chalasani N, Conforti A, Coulthard SA, Daly MJ, Day CP, Dillon JF, Fontana RJ, Grove JI, Hallberg P, Hernández N, Ibáñez L, Kullak-Ublick GA, Laitinen T, Larrey D, Lucena MI, Maitland-van der Zee AH, Martin JH, Molokhia M, Pirmohamed M, Powell EE, Qin S, Serrano J, Stephens C, Stolz A, Wadelius M, Watkins PB, Floratos A, Shen Y, Nelson MR, Urban TJ, Daly AK, International Drug-Induced Liver Injury Consortium, Drug-Induced Liver Injury Network Investigators, and International Serious Adverse Events Consortium.
- Issue date: 2017 Apr
- HLA-DRB1*16: 01-DQB1*05: 02 is a novel genetic risk factor for flupirtine-induced liver injury.
- Authors: Nicoletti P, Werk AN, Sawle A, Shen Y, Urban TJ, Coulthard SA, Bjornsson ES, Cascorbi I, Floratos A, Stammschulte T, Gundert-Remy U, Nelson MR, Aithal GP, Daly AK, International Drug-induced Liver Injury Consortium.
- Issue date: 2016 May
- Human Leukocyte Antigen B*14:01 and B*35:01 Are Associated With Trimethoprim-Sulfamethoxazole Induced Liver Injury.
- Authors: Li YJ, Phillips EJ, Dellinger A, Nicoletti P, Schutte R, Li D, Ostrov DA, Fontana RJ, Watkins PB, Stolz A, Daly AK, Aithal GP, Barnhart H, Chalasani N, Drug-induced Liver Injury Network.
- Issue date: 2021 Jan
- Single-nucleotide polymorphisms of <i>HLA</i> and <i>Polygonum multiflorum</i>-induced liver injury in the Han Chinese population.
- Authors: Yang WN, Pang LL, Zhou JY, Qiu YW, Miao L, Wang SY, Liu XZ, Tan KA, Shi WW, Wang GQ, Hou FQ
- Issue date: 2020 Mar 28